Jeffrey E. Russel

Array ( [id] => 4939395 [patent_doc_number] => 20080076714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Administration of gene-regulatory peptides' [patent_app_type] => utility [patent_app_number] => 11/982170 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19830 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076714.pdf [firstpage_image] =>[orig_patent_app_number] => 11982170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 168774 [patent_doc_number] => 07666986 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'Biologically active peptide comprising tyrosyl-seryl-valine (YSV)' [patent_app_type] => utility [patent_app_number] => 11/930171 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17850 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/666/07666986.pdf [firstpage_image] =>[orig_patent_app_number] => 11930171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4834136 [patent_doc_number] => 20080132683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'ISOLATION OF IMMUNOGLOBULINS' [patent_app_type] => utility [patent_app_number] => 11/930556 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23461 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132683.pdf [firstpage_image] =>[orig_patent_app_number] => 11930556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 33426 [patent_doc_number] => 07786084 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Treatment of burns' [patent_app_type] => utility [patent_app_number] => 11/981505 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 19864 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/786/07786084.pdf [firstpage_image] =>[orig_patent_app_number] => 11981505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4760181 [patent_doc_number] => 20080312407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Glycopeptide phosphonate derivatives' [patent_app_type] => utility [patent_app_number] => 11/977429 [patent_app_country] => US [patent_app_date] => 2007-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23104 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312407.pdf [firstpage_image] =>[orig_patent_app_number] => 11977429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585958 [patent_doc_number] => 20090105160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Pharmaceutical composition, package and method for rapidly reducing the uric acid in blood' [patent_app_type] => utility [patent_app_number] => 11/975969 [patent_app_country] => US [patent_app_date] => 2007-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2459 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105160.pdf [firstpage_image] =>[orig_patent_app_number] => 11975969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6574707 [patent_doc_number] => 20100129368 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2010-05-27 [patent_title] => 'Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the pH, compounds comprising the same, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/974186 [patent_app_country] => US [patent_app_date] => 2007-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22268 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0129/20100129368.pdf [firstpage_image] =>[orig_patent_app_number] => 11974186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6574707 [patent_doc_number] => 20100129368 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2010-05-27 [patent_title] => 'Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the pH, compounds comprising the same, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/974186 [patent_app_country] => US [patent_app_date] => 2007-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22268 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0129/20100129368.pdf [firstpage_image] =>[orig_patent_app_number] => 11974186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4814066 [patent_doc_number] => 20080194697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'NOVEL POLYAMINE ANALOG CONJUGATES AND QUINONE CONJUGATES AS THERAPIES FOR CANCERS AND PROSTATE DISEASES' [patent_app_type] => utility [patent_app_number] => 11/868910 [patent_app_country] => US [patent_app_date] => 2007-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 68 [patent_no_of_words] => 49175 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194697.pdf [firstpage_image] =>[orig_patent_app_number] => 11868910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8549463 [patent_doc_number] => 08324345 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'HLA-binding peptide, precursor thereof, DNA fragment and recombinant vector encoding the same' [patent_app_type] => utility [patent_app_number] => 12/444988 [patent_app_country] => US [patent_app_date] => 2007-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6589 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12444988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8664422 [patent_doc_number] => 08377883 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-19 [patent_title] => 'Peptide for anti-angiogenesis and use thereof' [patent_app_type] => utility [patent_app_number] => 12/443684 [patent_app_country] => US [patent_app_date] => 2007-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 18 [patent_no_of_words] => 13285 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12443684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8293989 [patent_doc_number] => 08221772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Pulmonary surfactant formulations and methods for promoting mucus clearance' [patent_app_type] => utility [patent_app_number] => 11/901866 [patent_app_country] => US [patent_app_date] => 2007-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 12617 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11901866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8211192 [patent_doc_number] => 20120129776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'Bioactive peptides and method of using same' [patent_app_type] => utility [patent_app_number] => 11/901939 [patent_app_country] => US [patent_app_date] => 2007-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 41811 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20120129776.pdf [firstpage_image] =>[orig_patent_app_number] => 11901939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5397263 [patent_doc_number] => 20090317326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'RADIOFLUORINATION METHODS' [patent_app_type] => utility [patent_app_number] => 11/851940 [patent_app_country] => US [patent_app_date] => 2007-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 25586 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 43 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317326.pdf [firstpage_image] =>[orig_patent_app_number] => 11851940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6222339 [patent_doc_number] => 20100056428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'MODIFIED PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/439221 [patent_app_country] => US [patent_app_date] => 2007-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22144 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056428.pdf [firstpage_image] =>[orig_patent_app_number] => 12439221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92198 [patent_doc_number] => 07732399 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Sustained release formulations' [patent_app_type] => utility [patent_app_number] => 11/847984 [patent_app_country] => US [patent_app_date] => 2007-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5404 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732399.pdf [firstpage_image] =>[orig_patent_app_number] => 11847984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5398290 [patent_doc_number] => 20090318353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Acylated Exendin-4 Compounds' [patent_app_type] => utility [patent_app_number] => 12/438280 [patent_app_country] => US [patent_app_date] => 2007-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15827 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318353.pdf [firstpage_image] =>[orig_patent_app_number] => 12438280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4916216 [patent_doc_number] => 20080096817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN BETA 4 (Tbeta4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 11/841575 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3192 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20080096817.pdf [firstpage_image] =>[orig_patent_app_number] => 11841575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4910216 [patent_doc_number] => 20080020983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'Peptides with antioxidant and antimicrobial properties' [patent_app_type] => utility [patent_app_number] => 11/891958 [patent_app_country] => US [patent_app_date] => 2007-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16136 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20080020983.pdf [firstpage_image] =>[orig_patent_app_number] => 11891958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7535225 [patent_doc_number] => 08048851 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-01 [patent_title] => 'Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response' [patent_app_type] => utility [patent_app_number] => 11/830497 [patent_app_country] => US [patent_app_date] => 2007-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 49745 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/048/08048851.pdf [firstpage_image] =>[orig_patent_app_number] => 11830497 [rel_patent_id] =>[rel_patent_doc_number] =>)